Data / Form D filings / Remedium Bio Inc.
Remedium Bio Inc.: Form D filings
Remedium Bio Inc., a biotechnology company in Needham, MA, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on May 18, 2026, reports $1.5 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1116 GREAT PLAIN AVENUE, Needham, MA, 02492
- Phone
- (617) 835-3434
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1892414
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | New notice | $10,000,000 | $1,500,000 | $8,500,000 | 1 | May 6, 2026 | sec.gov |
| Aug 28, 2024 | Amendment | $7,250,000 | $4,434,955 | $2,815,045 | 26 | Nov 5, 2021 | sec.gov |
| Nov 9, 2021 | New notice | $2,300,000 | $1,370,000 | $930,000 | 6 | Nov 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Luppino | Executive Officer, Director | |
| Alexei Goraltchouk | Executive Officer, Director | |
| Richard Hague | Director | |
| Harry Robb | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 18, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Remedium Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.